Cargando…

Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate

Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomer...

Descripción completa

Detalles Bibliográficos
Autores principales: Winterhoff, Moritz, Chen, Fangfang, Sahini, Nishika, Ebensen, Thomas, Kuhn, Maike, Kaever, Volkhard, Bähre, Heike, Pessler, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146994/
https://www.ncbi.nlm.nih.gov/pubmed/33925995
http://dx.doi.org/10.3390/metabo11050270
_version_ 1783697526852943872
author Winterhoff, Moritz
Chen, Fangfang
Sahini, Nishika
Ebensen, Thomas
Kuhn, Maike
Kaever, Volkhard
Bähre, Heike
Pessler, Frank
author_facet Winterhoff, Moritz
Chen, Fangfang
Sahini, Nishika
Ebensen, Thomas
Kuhn, Maike
Kaever, Volkhard
Bähre, Heike
Pessler, Frank
author_sort Winterhoff, Moritz
collection PubMed
description Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomers of itaconate that have been linked to metabolic disorders, but their functional relationships with itaconate are unknown. We aimed to establish a sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the quantification of itaconate, mesaconate, citraconate, the pro-drug 4-octyl-itaconate, and selected TCA intermediates. The assay was validated for itaconate, mesaconate, and citraconate for intra- and interday precision and accuracy, extended stability, recovery, freeze/thaw cycles, and carry-over. The lower limit of quantification was 0.098 µM for itaconate and mesaconate and 0.049 µM for citraconate in 50 µL samples. In spike-in experiments, itaconate remained stable in human plasma and whole blood for 24 and 8 h, respectively, whereas spiked-in citraconate and mesaconate concentrations changed during incubation. The type of anticoagulant in blood collection tubes affected measured levels of selected TCA intermediates. Human plasma may contain citraconate (0.4–0.6 µM, depending on the donor), but not itaconate or mesaconate, and lipopolysaccharide stimulation of whole blood induced only itaconate. Concentrations of the three isomers differed greatly among mouse organs: Itaconate and citraconate were most abundant in lymph nodes, mesaconate in kidneys, and only citraconate occurred in brain. This assay should prove useful to quantify itaconate isomers in biomarker and pharmacokinetic studies, while providing internal controls for their effects on metabolism by allowing quantification of TCA intermediates.
format Online
Article
Text
id pubmed-8146994
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81469942021-05-26 Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate Winterhoff, Moritz Chen, Fangfang Sahini, Nishika Ebensen, Thomas Kuhn, Maike Kaever, Volkhard Bähre, Heike Pessler, Frank Metabolites Article Itaconate is derived from the tricarboxylic acid (TCA) cycle intermediate cis-aconitate and links innate immunity and metabolism. Its synthesis is altered in inflammation-related disorders and it therefore has potential as clinical biomarker. Mesaconate and citraconate are naturally occurring isomers of itaconate that have been linked to metabolic disorders, but their functional relationships with itaconate are unknown. We aimed to establish a sensitive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the quantification of itaconate, mesaconate, citraconate, the pro-drug 4-octyl-itaconate, and selected TCA intermediates. The assay was validated for itaconate, mesaconate, and citraconate for intra- and interday precision and accuracy, extended stability, recovery, freeze/thaw cycles, and carry-over. The lower limit of quantification was 0.098 µM for itaconate and mesaconate and 0.049 µM for citraconate in 50 µL samples. In spike-in experiments, itaconate remained stable in human plasma and whole blood for 24 and 8 h, respectively, whereas spiked-in citraconate and mesaconate concentrations changed during incubation. The type of anticoagulant in blood collection tubes affected measured levels of selected TCA intermediates. Human plasma may contain citraconate (0.4–0.6 µM, depending on the donor), but not itaconate or mesaconate, and lipopolysaccharide stimulation of whole blood induced only itaconate. Concentrations of the three isomers differed greatly among mouse organs: Itaconate and citraconate were most abundant in lymph nodes, mesaconate in kidneys, and only citraconate occurred in brain. This assay should prove useful to quantify itaconate isomers in biomarker and pharmacokinetic studies, while providing internal controls for their effects on metabolism by allowing quantification of TCA intermediates. MDPI 2021-04-26 /pmc/articles/PMC8146994/ /pubmed/33925995 http://dx.doi.org/10.3390/metabo11050270 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Winterhoff, Moritz
Chen, Fangfang
Sahini, Nishika
Ebensen, Thomas
Kuhn, Maike
Kaever, Volkhard
Bähre, Heike
Pessler, Frank
Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title_full Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title_fullStr Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title_full_unstemmed Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title_short Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
title_sort establishment, validation, and initial application of a sensitive lc-ms/ms assay for quantification of the naturally occurring isomers itaconate, mesaconate, and citraconate
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146994/
https://www.ncbi.nlm.nih.gov/pubmed/33925995
http://dx.doi.org/10.3390/metabo11050270
work_keys_str_mv AT winterhoffmoritz establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT chenfangfang establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT sahininishika establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT ebensenthomas establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT kuhnmaike establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT kaevervolkhard establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT bahreheike establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate
AT pesslerfrank establishmentvalidationandinitialapplicationofasensitivelcmsmsassayforquantificationofthenaturallyoccurringisomersitaconatemesaconateandcitraconate